Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)		9 Months Ended
		Sep. 30, 2022		Sep. 30, 2021
Cash flows from operating activities:
Net income		$ 11,089,000,000		$ 5,817,000,000
Loss from discontinued operations, net of income taxes		1,000,000		0
Noncash revenues, expenses, gains and losses included in income (loss):
Net (gains) losses on sales of securities available for sale and other assets		737,000,000		(1,141,000,000)
Net gain on divestitures		(45,000,000)		(108,000,000)
Loss on extinguishment of debt		299,000,000		149,000,000
Unrealized gains in earnings - net		(2,738,000,000)		(1,295,000,000)
Equity in (income) loss from equity method investments, net of dividends or distributions		(159,000,000)		14,000,000
Depreciation and other amortization		3,918,000,000		3,590,000,000
Impairments of assets		12,000,000		19,000,000
Changes in operating assets and liabilities:
Insurance reserves		1,720,000,000		5,829,000,000
Premiums and other receivables and payables - net		(8,914,000,000)		(1,387,000,000)
Reinsurance assets, net		200,000,000		(1,739,000,000)
Capitalization of deferred policy acquisition costs		(3,704,000,000)		(3,858,000,000)
Current and deferred income taxes - net		2,424,000,000		497,000,000
Other, net		(822,000,000)		(623,000,000)
Total adjustments		(7,072,000,000)		(53,000,000)
Net cash provided by operating activities		4,018,000,000		5,764,000,000
Sales or distributions of:
Available for sale securities		17,296,000,000		19,211,000,000
Other securities		1,288,000,000		703,000,000
Other invested assets		2,239,000,000		3,298,000,000
Divestitures, net		0		137,000,000
Maturities of fixed maturity securities available for sale		14,702,000,000		26,424,000,000
Principal payments received on and sales of mortgage and other loans receivable		6,064,000,000		5,684,000,000
Purchases of:
Available for sale securities		(28,896,000,000)		(53,220,000,000)
Other securities		(3,198,000,000)		(128,000,000)
Other invested assets		(1,701,000,000)		(2,134,000,000)
Mortgage and other loans receivable		(9,824,000,000)		(6,156,000,000)
Net change in short-term investments		(1,599,000,000)		4,569,000,000
Other, net		1,364,000,000		(1,312,000,000)
Net cash used in investing activities		(2,265,000,000)		(2,924,000,000)
Proceeds from (payments for)
Policyholder contract deposits		19,779,000,000		19,522,000,000
Policyholder contract withdrawals		(14,736,000,000)		(16,208,000,000)
Issuance of debt		7,473,000,000		79,000,000
Repayments of debt		(7,649,000,000)		(3,451,000,000)
Borrowings under delayed draw term loan agreement		1,502,000,000		0
Purchase of common stock		(4,398,000,000)		(1,651,000,000)
Dividends paid on preferred stock		(22,000,000)		(22,000,000)
Dividends paid on common stock		(746,000,000)		(819,000,000)
Other, net		(2,511,000,000)		(458,000,000)
Net cash used in financing activities		(1,571,000,000)		(2,760,000,000)
Effect of exchange rate changes on cash and restricted cash		(114,000,000)		(40,000,000)
Net increase in cash and restricted cash		69,000,000		40,000,000
Cash and restricted cash at beginning of year		2,427,000,000		3,230,000,000
Change in cash of held for sale assets		0		(436,000,000)
Cash and restricted cash at end of period		2,496,000,000		2,834,000,000
Cash Equivalents, Restricted Cash and Restricted Cash Equivalents:
Cash		2,294,000,000	[1]	2,699,000,000
Total cash and restricted cash shown in the Condensed Consolidated Statements of Cash Flows		2,496,000,000		2,834,000,000
Cash paid during the period for:
Interest		734,000,000		781,000,000
Taxes		489,000,000		737,000,000
Non-cash investing activities:
Fixed maturity securities available for sale received in connection with pension risk transfer transactions		0		797,000,000
Fixed maturity securities received in connection with reinsurance transactions		2,000,000		58,000,000
Fixed maturity securities transferred in connection with reinsurance transactions		(212,000,000)		(734,000,000)
Non-cash financing activities:
Interest credited to policyholder contract deposits included in financing activities		2,615,000,000		2,691,000,000
Fee income debited to policyholder contract deposits included in financing activities		(1,268,000,000)		(1,267,000,000)
Consolidated VIE
Proceeds from (payments for)
Issuance of debt		849,000,000		3,458,000,000
Repayments of debt		(1,112,000,000)		(3,210,000,000)
Cash Equivalents, Restricted Cash and Restricted Cash Equivalents:
Cash		82,000,000
Short-term investments
Cash Equivalents, Restricted Cash and Restricted Cash Equivalents:
Restricted cash	[2]	133,000,000		77,000,000
Other assets
Cash Equivalents, Restricted Cash and Restricted Cash Equivalents:
Restricted cash	[2]	$ 69,000,000		$ 58,000,000

[1] See Note 8 for details of balances associated with variable interest entities.

[2] Includes funds held for tax sharing payments to AIG Parent, security deposits, and replacement reserve deposits related to real estate.